Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Xavier Poiré"'
Autor:
Zachary D. Epstein-Peterson, Andriy Derkach, Susan Geyer, Krzysztof Mrózek, Jessica Kohlschmidt, Jae H. Park, Sridevi Rajeeve, Eytan M. Stein, Yanming Zhang, Harry Iland, Lynda J. Campbell, Richard A. Larson, Xavier Poiré, Bayard L. Powell, Wendy Stock, Richard M. Stone, Martin S. Tallman
Publikováno v:
Blood Advances. 6:3433-3439
Frontline arsenic trioxide (ATO)–based treatment regimens achieve high rates of long-term relapse-free survival in treating acute promyelocytic leukemia (APL) and form the current standard of care. Refining prognostic estimates for newly diagnosed
Autor:
Joanna Drozd-Sokolowska, Luuk Gras, Nienke Zinger, Jorge Sierra, Montserrat Rovira, Urpu Salmenniemi, Teresa Zudaire, Arancha Bermúdez, Goda Choi, Matthew P. Collin, Martin Kaufmann, Piotr Kozlowski, Xavier Poiré, Josep-Maria Ribera, Antonia Sampol, Keith Wilson, Michel A. Duchosal, Tobias Gedde-Dahl, Eric Deconinck, Milena Mirabile, Kavita Raj, Michel Van Gelder, Olivier Tournilhac, Donal P. McLornan, Ibrahim Yakoub-Agha
Publikováno v:
Blood. 140:4848-4850
Autor:
Xavier Poiré, Rik Schots, Johan Maertens, Aurélie Ory, Etienne Baudoux, Pierre Zachee, Frédéric Baron, Dominik Selleslag, Julie Herman, Carlos Graux, Alexandra Briquet, Yves Beguin, Sophie Servais, Wilfried Schroyens, Tessa Kerre, Chantal Lechanteur
Publikováno v:
Blood, Vol. 134, no.Supplement_1, p. 37-37 (2019)
Poor graft function (PGF) is a rare but serious complication of hematopoietic cell transplantation (HCT). Boost of CD34+stem cells could be a therapeutic option but is not always feasible nor successfull. Due to their hematopoietic support properties
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb40be685f8e95cc39b3fb3a4284647
https://biblio.vub.ac.be/vubir/multipotent-mesenchymal-stromal-cells-for-poor-graft-function-after-allogeneic-hematopoietic-cell-transplantationa-multicenter-prospective-study(5aea11e4-a25c-4aac-86bd-936fee611942).html
https://biblio.vub.ac.be/vubir/multipotent-mesenchymal-stromal-cells-for-poor-graft-function-after-allogeneic-hematopoietic-cell-transplantationa-multicenter-prospective-study(5aea11e4-a25c-4aac-86bd-936fee611942).html
Autor:
Raynier Devillier, Yves Beguin, Sara Villar, Jacques-Olivier Bay, David Beauvais, Marie Robin, Nicole Raus, Amandine Charbonnier, Stéphanie Nguyen, Marie-Thérèse Rubio, Patrice Chevallier, Xavier Poiré, Remy Dulery, Sylvain Chantepie, Patrice Ceballos, Sylvie Chevret, Jean-Henri Bourhis, Michael Loschi, Edouard Forcade
Publikováno v:
Blood. 138:1844-1844
Background: Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only curative therapy in patients with primary or secondary myelofibrosis. Ruxolitinib, a JAK-inhibitor, has been approved in myelofibrosis patients and is effective to
Autor:
Francesco Onida, Marie Robin, Xavier Poiré, Goda Choi, Christof Scheid, Ibrahim Yakoub-Agha, Linda Koster, Didier Blaise, Hendrik Veelken, Micha Srour, Yves Beguin, Nathalie Fegueux, Patrick Hayden, Francesca A M Kinsella, Thomas Schroeder, Jean-Henri Bourhis, Johan Maertens, Urpu Salmenniemi, Patrice Chevallier, Jan J. Cornelissen, Arancha Bermudez Rodriguez, Diderik-jan Eikeman, Jürgen Kuball, Jakob Passweg, Jennifer Byrne
Publikováno v:
Blood. 138:3953-3953
INTRODUCTION: Myelodysplastic Syndrome (MDS) is a heterogenous disease which is almost incurable without an allogeneic hematopoietic cell transplantation (allo-HCT). Within the revised international scoring system (R-IPSS), MDS with poor and very poo
Autor:
Nathalie Fegueux, Marie Robin, Marie-Thérèse Rubio, Patrice Chevallier, Edouard Forcade, Johan Maertens, Jean-Baptiste Mear, Yves Chalandon, Jean-Hugues Dalle, Xavier Poiré, Tereza Coman, Stephane Morisset, Remy Dulery, Hélène Labussière, Nicole Raus, Stephanie Nguyen Quoc, Jean-Henri Bourhis, Claude-Eric Bulabois, Ibrahim Yakoub-Agha, Mauricette Michallet, Raynier Devillier, Anne Huynh, Mohamad Sobh
Publikováno v:
Blood. 138:2883-2883
Rational: The significant increase in haplo-identical allogeneic cell transplantation (Allo-HCT) has led to the more frequent use of cyclophosphamide (Cy) after transplantation for graft-versus-host disease (GVHD) prophylaxis (PT-Cy). This strategy h
Autor:
Patrice Chevallier, Remy Gressin, Benoit Tessoulin, Steven Le Gouill, Michael Loschi, Mathilde Hunault, Adrien Chauchet, Philippe Lewalle, Natacha Maillard, Sabine Furst, Amandine Le Bourgeois, Remy Dulery, Baptiste Le Calvez, Xavier Poiré, David Sibon, Gaelle Guillerm, Loïc Renaud, Jean-Jacques Tudesq, Carmen Botella-Garcia, Stéphanie Nguyen, Vincent Camus, Micha Srour, Alban Villate, Amandine Fayard, Yves Beguin
Publikováno v:
Blood. 138:1826-1826
Introduction: Primary mediastinal B cells lymphoma (PMBCL) is a rare subtype of aggressive non Hodgkin lymphoma (NHL). Despite therapeutic progresses, 10 to 30% of PMBCL patients are primary refractory or experience early relapses (R/R). Despite Auto
Autor:
Myriam Labopin, Igor Wolfgang Blau, Tobias Gedde-Dahl, Ibrahim Yakoub-Agha, Claude-Eric Bulabois, Jordi Esteve, Nicolaus Kröger, Emmanuelle Polge, Gérard Socié, Jürgen Finke, Xavier Poiré, Mahmoud Aljurf, Arnold Ganser, Arnon Nagler, Mohamad Mohty, Edouard Forcade, Yves Chalandon
Publikováno v:
Blood. 138:3952-3952
Introduction: Cytogenetics remains one of the most important prognostic factors in acute myeloid leukemia (AML) patients, even for outcomes after allogeneic hematopoietic cell transplantation (allo-HCT). Complex karyotype (CK) constitutes a cytogenet
Autor:
A. Samer Al-Homsi, Marie-Sophie Dheur, Nathalie Braun, Daniel A. Pollyea, David A. Sallman, Ine Moors, David E. Gilham, Anne Flament, William Blum, Frederic Lehmann, Erik Alcantar-Orozco, Philippe Lewalle, Caroline Lonez, Eytan Breman, Violaine Havelange, Marco L. Davila, Tessa Kerre, Xavier Poiré, Panagiota A. Sotiropoulou, Eunice S. Wang, Benjamin Demoulin
Publikováno v:
Blood. 136:40-41
Background CYAD-01 is a T-cell product engineered to express a chimeric antigen receptor (CAR) based on the NKG2D receptor (NKG2D CAR) which binds 8 ligands (MICA/B, ULBP1-6) over-expressed by a large variety of malignancies, including acute myeloid
Autor:
Myriam Labopin, Ram Malladi, Xavier Poiré, Bipin N. Savani, Jean Bourhis, Mohamad Mohty, Bhagirathbhai Dholaria, Jan J. Cornelissen, Péter Reményi, Arnon Nagler, Tessa Kerre, Riitta Niittyvuopio, Johan Maertens, Wilfried Schroyens, Yves Beguin
Publikováno v:
Blood advances, 3(13), 1950-1960. American Society of Hematology
BLOOD ADVANCES
Blood advances, Vol. 3, no.13, p. 1950-1960 (2019)
BLOOD ADVANCES
Blood advances, Vol. 3, no.13, p. 1950-1960 (2019)
The impact of the use of antithymocyte globulin (ATG) following a total body irradiation (TBI)-based myeloablative conditioning regimen has been poorly explored. We retrospectively analyzed 724 patients who underwent a first allogeneic hematopoietic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5087e99a7b5123af7318fcd0e7f5f30d
https://europepmc.org/articles/PMC6616257/
https://europepmc.org/articles/PMC6616257/